S. 2026Senate109th Congress (2005-2007)In Committee

Medicare Prescription Drug Gap Disclosure Act

Introduced November 16, 2005

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S12959)

November 16, 2005

View full timeline
SenateIntro Referral

Introduced in Senate

November 16, 2005

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S12958-12959)

November 16, 2005

SenateIntro Referral

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S12959)

November 16, 2005

Floor Debate

9 members

What members said about S. 2026 on the floor

5 Republicans4 Democrats
Joseph I. Lieberman
Sen. Joseph I. LiebermanD-CT · Nov 16, 2005

Mr. President, our dependence on foreign oil is sapping America's power and independence as a nation. It is urgent we begin now to diversify the fuels we use to power our vehicles or risk ceding our…

Russell D. Feingold
Sen. Russell D. FeingoldD-WI · Nov 16, 2005

Mr. President, today I plan to introduce the Equal Access to Justice Reform Act of 2005. This legislation contains adjustments to the Equal Access to Justice Act (EAJA) that will streamline and…

Olympia J. Snowe
Sen. Olympia J. SnoweR-ME · Nov 16, 2005

Mr. President, as Chair of the Senate Committee on Small Business and Entrepreneurship, I have fought to ensure that small businesses across the country are treated fairly by the Federal Government.…

Norm Coleman
Sen. Norm ColemanR-MN · Nov 16, 2005

Mr. President, constituents across the country in rural areas face serious health care issues, not only in terms of illness but also in lack of easily accessible services. One out of every five…

Saxby Chambliss
Sen. Saxby ChamblissR-GA · Nov 16, 2005

Mr. President, I rise today to introduce my bill, the ``Disabled Veterans Sports and Special Events Promotion Act of 2005''. We discovered during World War II that sports and physical activity play a…

Show 5 more
Frank R. Lautenberg
Sen. Frank R. LautenbergD-NJ · Nov 16, 2005

Mr. President, I rise to introduce the Medicare Prescription Drug Gap Disclosure Act with my colleagues, Senators Kerry, Dorgan and Dayton. This important legislation will require Medicare…

Frank R. Lautenberg
Sen. Frank R. LautenbergD-NJ · Nov 16, 2005

Mr. President, I rise to introduce the Medicare Prescription Drug Gap Disclosure Act with my colleagues, Senators Kerry, Dorgan and Dayton. This important legislation will require Medicare…

Max Baucus
Sen. Max BaucusD-MT · Nov 16, 2005

Mr. President, I am pleased to introduce with Senator Smith a bill that would provide for the establishment of voluntary, ``health-based'' remediation guidelines for former methamphetamine…

Lisa Murkowski
Sen. Lisa MurkowskiR-AK · Nov 16, 2005

Mr. President, I rise to introduce a bill that will increase the minimum funding level for low population States for the U.S. Department of Housing and Urban Development's HOME Investment…

Chuck Grassley
Sen. Chuck GrassleyR-IA · Nov 16, 2005

Mr. President, I ask unanimous consent that the text of this bill be printed in the Record.

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued November 16, 2005

II

109th CONGRESS

1st Session

S. 2026

IN THE SENATE OF THE UNITED STATES

November 16, 2005

Mr. Lautenberg (for himself, Mr. Kerry, Mr. Dorgan, and Mr. Dayton) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To amend title XVIII of the Social Security Act to require that a prescription drug plan or an MA–PD plan that has an initial coverage limit obtain a signed certification prior to enrolling beneficiaries under the plan under part D of such title.

1.

Short title

This Act may be cited as the Medicare Prescription Drug Gap Disclosure Act.

2.

Requirement of signed certification prior to plan enrollment under part D

(a)

In general

Section 1860D–1(b)(1) of the Social Security Act (42 U.S.C. 1395w–101) is amended by adding at the end the following new subparagraph:

(D)

Special rule for plans with an initial coverage limit

(i)

In general

The process for enrollment established under subparagraph (A) shall include, in the case of a prescription drug plan or an MA–PD plan that has an initial coverage limit (as described in section 1860D–2(b)(3)), a requirement that, prior to enrolling a part D eligible individual in the plan, the plan must obtain a certification signed by the enrollee or the legal guardian of the enrollee that meets the requirements described in clause (ii) and includes the following text: I understand that the Medicare Prescription Drug Plan or MA–PD Plan that I am signing up for may result in a gap in coverage during a given year. I understand that if subject to this gap in coverage, I will be responsible for paying 100 percent of the cost of my prescription drugs and will continue to be responsible for paying the plan’s monthly premium while subject to this gap in coverage. For specific information on the potential coverage gap under this plan, I understand that I should contact (insert name of the sponsor of the prescription drug plan or the sponsor of the MA–PD plan) at (insert toll free phone number for such sponsor of such plan)..

(ii)

Certification requirements described

The certification required under clause (i) shall meet the following requirements:

(I)

The certification shall be printed in a typeface of not less than 18 points.

(II)

The certification shall be printed on a single piece of paper separate from any matter not related to the certification.

(III)

The certification shall have a heading printed at the top of the page in all capital letters and bold face type that states the following: WARNING: POTENTIAL MEDICARE PRESCRIPTION DRUG COVERAGE GAP.

.

(b)

Effective date

The amendment made by this section shall take effect on the date of enactment of this Act.